AIM ImmunoTech adjourns annual shareholder meeting to Dec. 8 for lack of quorum
AIM•AIM ImmunoTech adjourned its 2026 annual shareholder meeting from Nov. 17 to Dec. 8 after proxies represented about 32.5% of shares, below the 33.33% quorum requirement.
1. Meeting rescheduled
AIM ImmunoTech adjourned its 2026 annual shareholder meeting from Nov. 17 to Dec. 8 because it lacked a quorum. The meeting will reconvene virtually at 11 a.m. Eastern Time.
2. Voting details
The Sept. 28 record date and voting proposals remain unchanged, and votes previously submitted remain valid. The company said the delay gives shareholders additional time to review proxy materials and vote.



